Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Amoxicillin | 1 | 2019 | 98 | 0.73 | Why? |
| Salmonella typhi | 1 | 2019 | 98 | 0.73 | Why? |
| Typhoid Fever | 1 | 2019 | 139 | 0.68 | Why? |
| Ceftriaxone | 1 | 2019 | 365 | 0.65 | Why? |
| Henipavirus Infections | 1 | 2018 | 122 | 0.64 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2019 | 1115 | 0.52 | Why? |
| Disease Reservoirs | 1 | 2018 | 1672 | 0.37 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.35 | Why? |
| Singapore | 13 | 2021 | 3641 | 0.34 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 2 | 2017 | 711 | 0.21 | Why? |
| Cross Infection | 7 | 2021 | 8675 | 0.21 | Why? |
| Phoeniceae | 1 | 2018 | 4 | 0.19 | Why? |
| Vancomycin Resistance | 1 | 2018 | 55 | 0.19 | Why? |
| Genome, Bacterial | 2 | 2019 | 446 | 0.18 | Why? |
| Abattoirs | 1 | 2018 | 94 | 0.18 | Why? |
| Carbapenems | 2 | 2018 | 343 | 0.17 | Why? |
| Staphylococcal Infections | 2 | 2017 | 1099 | 0.17 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2018 | 104 | 0.17 | Why? |
| Streptococcus pyogenes | 1 | 2018 | 118 | 0.17 | Why? |
| Health Personnel | 6 | 2020 | 29646 | 0.17 | Why? |
| Nipah Virus | 1 | 2018 | 121 | 0.17 | Why? |
| Plasmids | 1 | 2019 | 840 | 0.15 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.14 | Why? |
| Environmental Microbiology | 1 | 2020 | 575 | 0.14 | Why? |
| Central Nervous System Diseases | 1 | 2020 | 410 | 0.14 | Why? |
| Acinetobacter Infections | 1 | 2018 | 273 | 0.14 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2018 | 323 | 0.14 | Why? |
| Streptococcal Infections | 1 | 2018 | 255 | 0.14 | Why? |
| Acinetobacter baumannii | 1 | 2018 | 378 | 0.14 | Why? |
| London | 1 | 2020 | 2166 | 0.13 | Why? |
| Malaysia | 1 | 2018 | 1116 | 0.13 | Why? |
| Anti-Bacterial Agents | 4 | 2019 | 10083 | 0.12 | Why? |
| Hospitals | 4 | 2020 | 11793 | 0.12 | Why? |
| Respiratory Protective Devices | 2 | 2014 | 1637 | 0.12 | Why? |
| Bangladesh | 1 | 2018 | 1620 | 0.12 | Why? |
| Health Facilities | 2 | 2017 | 1230 | 0.12 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.11 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.11 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.11 | Why? |
| Encephalitis | 1 | 2018 | 797 | 0.10 | Why? |
| Medication Adherence | 1 | 2019 | 1270 | 0.10 | Why? |
| Swine | 1 | 2018 | 3352 | 0.09 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.09 | Why? |
| Long-Term Care | 2 | 2018 | 2047 | 0.09 | Why? |
| Bacteria | 1 | 2019 | 1897 | 0.09 | Why? |
| Hand Hygiene | 1 | 2017 | 1493 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Feces | 2 | 2019 | 4235 | 0.08 | Why? |
| Fluoroimmunoassay | 1 | 2005 | 36 | 0.08 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.07 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Personnel, Hospital | 1 | 2017 | 2273 | 0.07 | Why? |
| Severe Acute Respiratory Syndrome | 5 | 2005 | 12361 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Chiroptera | 1 | 2018 | 3530 | 0.06 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.06 | Why? |
| Humans | 27 | 2021 | 930598 | 0.06 | Why? |
| Masks | 2 | 2014 | 8528 | 0.06 | Why? |
| Personal Protective Equipment | 3 | 2020 | 15978 | 0.05 | Why? |
| India | 1 | 2018 | 11875 | 0.05 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.05 | Why? |
| Disease Outbreaks | 4 | 2020 | 27595 | 0.05 | Why? |
| Nervous System | 1 | 2020 | 303 | 0.04 | Why? |
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2017 | 72 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2018 | 264 | 0.04 | Why? |
| Intermediate Care Facilities | 1 | 2017 | 59 | 0.04 | Why? |
| Ribavirin | 1 | 2004 | 1182 | 0.04 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.04 | Why? |
| Intubation | 1 | 2018 | 437 | 0.04 | Why? |
| Membrane Glycoproteins | 1 | 2005 | 2273 | 0.04 | Why? |
| Likelihood Functions | 1 | 2018 | 719 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Databases, Nucleic Acid | 1 | 2018 | 272 | 0.04 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.04 | Why? |
| Body Temperature | 1 | 2020 | 875 | 0.04 | Why? |
| Particle Size | 1 | 2020 | 1052 | 0.04 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| SARS Virus | 4 | 2005 | 13021 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Animals | 3 | 2020 | 78931 | 0.03 | Why? |
| Ventilation | 1 | 2020 | 1145 | 0.03 | Why? |
| Neuroimaging | 1 | 2020 | 1106 | 0.03 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.03 | Why? |
| Cross-Sectional Studies | 5 | 2020 | 53120 | 0.03 | Why? |
| Hospitals, Psychiatric | 1 | 2018 | 506 | 0.03 | Why? |
| Nucleocapsid Proteins | 1 | 2005 | 3120 | 0.03 | Why? |
| Viral Envelope Proteins | 1 | 2005 | 3539 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2018 | 1638 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2017 | 652 | 0.03 | Why? |
| Male | 12 | 2021 | 367725 | 0.03 | Why? |
| Emigrants and Immigrants | 1 | 2020 | 888 | 0.03 | Why? |
| Female | 12 | 2021 | 380317 | 0.03 | Why? |
| Infectious Disease Medicine | 1 | 2014 | 311 | 0.03 | Why? |
| Nose | 1 | 2017 | 1093 | 0.03 | Why? |
| Hygiene | 1 | 2018 | 987 | 0.03 | Why? |
| Prevalence | 3 | 2017 | 25773 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Sentinel Surveillance | 1 | 2018 | 1093 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.03 | Why? |
| Middle East | 1 | 2014 | 1418 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Occupational Diseases | 1 | 2004 | 2787 | 0.02 | Why? |
| Data Collection | 1 | 2017 | 1769 | 0.02 | Why? |
| Particulate Matter | 1 | 2020 | 3249 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Family Characteristics | 1 | 2017 | 2551 | 0.02 | Why? |
| Adult | 8 | 2021 | 244371 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Skin | 1 | 2018 | 2096 | 0.02 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.02 | Why? |
| Aged | 5 | 2021 | 215776 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.02 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.02 | Why? |
| General Surgery | 1 | 2017 | 1472 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Medical Laboratory Personnel | 1 | 2004 | 254 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2005 | 51949 | 0.01 | Why? |
| Inpatients | 1 | 2017 | 5161 | 0.01 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Recombinant Fusion Proteins | 1 | 2005 | 919 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 2005 | 3198 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.01 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| RNA, Viral | 1 | 2004 | 32276 | 0.01 | Why? |
| Base Sequence | 1 | 2005 | 3581 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Travel | 1 | 2014 | 7220 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Sequence Analysis, DNA | 1 | 2004 | 2830 | 0.01 | Why? |
| Radiography | 1 | 2003 | 1576 | 0.01 | Why? |
| Critical Care | 1 | 2018 | 14081 | 0.01 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.01 | Why? |
| DNA, Viral | 1 | 2004 | 2521 | 0.01 | Why? |
| Convalescence | 1 | 2004 | 2829 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2014 | 8843 | 0.01 | Why? |
| Proportional Hazards Models | 1 | 2004 | 6543 | 0.01 | Why? |
| Laboratories | 1 | 2004 | 2858 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Cough | 1 | 2003 | 4891 | 0.01 | Why? |
| Communicable Diseases, Emerging | 1 | 2003 | 2523 | 0.01 | Why? |
| Public Health | 1 | 2014 | 16359 | 0.01 | Why? |
| Treatment Outcome | 2 | 2004 | 51732 | 0.01 | Why? |
| Fever | 1 | 2003 | 7795 | 0.00 | Why? |
| Phylogeny | 1 | 2004 | 13341 | 0.00 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 13720 | 0.00 | Why? |
| Biomedical Research | 1 | 2004 | 5270 | 0.00 | Why? |
| Genome, Viral | 1 | 2004 | 13157 | 0.00 | Why? |
| Hospital Mortality | 1 | 2004 | 22087 | 0.00 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2005 | 37182 | 0.00 | Why? |
| Retrospective Studies | 1 | 2004 | 105322 | 0.00 | Why? |
Ang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(174)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(94)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_